Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

672
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
672
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

578
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
578
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.2K
The pathophysiology of pneumonia involves the following steps:
2.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

636
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
636
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.3K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A Pilot Clinical Trial to Assess the Effect of Intermittent Inhaled Nitric Oxide as Treatment of Nontuberculous Mycobacteria Lung Infection.

Annals of the American Thoracic Society·2025
Same author

Culture result discrepancy between laboratories for nontuberculous mycobacteria in people with cystic fibrosis.

Pediatric pulmonology·2023
Same author

Alarmins and innate lymphoid cells 2 activation: A common pathogenetic link connecting respiratory syncytial virus bronchiolitis and later wheezing/asthma?

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2022
Same author

Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.

PloS one·2022
Same author

Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. systemic corticosteroids.

Pediatric pulmonology·2021
Same author

Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.

Pediatric pulmonology·2021

関連する実験動画

Updated: Dec 9, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.4K

子どもにおける合併症性肺炎

Fernando M de Benedictis1, Eitan Kerem2, Anne B Chang3

  • 1Salesi Children's Hospital Foundation, Ancona, Italy.

Lancet (London, England)
|September 13, 2020
PubMed
まとめ

子供のコミュニティでの合併症性肺炎は重症であるが,治療可能である. 早期の疑惑と適切な抗生物質は,画像と培養によって導かれ,排水がしばしば十分な治療によって回復します.

さらに関連する動画

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.5K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.7K

関連する実験動画

Last Updated: Dec 9, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.4K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.5K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.7K

科学分野:

  • 小児科
  • 感染症
  • 肺科

背景:

  • 合併症性地域性肺炎 (CCAP) は,小児における局所的および全身的な合併症を伴う.
  • 肺炎が48~72時間以内に抗生物質に反応しない場合,CCAPは迅速な認識と治療を必要とします.

研究 の 目的:

  • 子供のコミュニティで発症する 合併症性肺炎の診断と管理の戦略を概説する.
  • 早期発見と適切な治療の重要性を強調し,好ましい結果を保証する.

主な方法:

  • 初期診断は胸部X線写真と超音波で 肺パレンキマと胞液の評価を行う.
  • 治療には,微生物学的データに基づいて,静脈内および経口抗生物質の長期投与が含まれます.
  • 胸腔液の分析とイメージングは,胸腔内フィブリノリチクと排水手順に関する決定を導く.

主要な成果:

  • 肺炎菌と黄金菌は一般的な病原体である.
  • ほとんどの症例は抗生物質と膜排水で治療され,大規模な手術はめったに必要ありません.
  • 特に死滅性肺炎の場合,潜在的に長い経過にもかかわらず,完全な回復は典型的な結果です.

結論:

  • 早期の疑惑と診断と治療の構造的なアプローチは,小児CCAPの管理に不可欠です.
  • 抗生物質の選択は微生物学によって導かれ 胸膜の排水などの適切な介入が 治療の成功の鍵となります
  • CCAPは重症であるが,適切な治療をすれば,一般的に治る状態である.